Breaking News: Video Interview With Harry Zhabilov of Immunotech Laboratories
HUNTINGTON BEACH, Calif., Feb. 12, 2013 /PRNewswire/ -- Recently, Immunotech Laboratories (IMMB) President Harry Zhabilov and Director Bo Linton welcomed UndiscoveredCompanies.com into their facilities to conduct an interview.
Part I of the video series was released earlier this month featuring newly appointed Director Bo Linton. In Part II, we discuss the company, its goals, and treatments with the founder, President Harry Zhabilov.
Topics discussed with Harry Zhabilov include the addition of new board members, goals of up-listing to NASDAQ, the FDA, and how the immunotherapy treatment works.
The newly released Part II can be viewed at http://youtu.be/oPFso7SiCYs
For those whom have not seen it yet, the first part featuring Company Director Mr. Bo Linton can be viewed at http://www.youtube.com/watch?v=uCjNAf30aeo
About Immunotech Laboratories
Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases such as HIV, Cancer, Hepatitis and AIDS. Immunotech is committed to creating drugs for the better health of mankind.
About Undiscovered Companies
Undiscovered Companies is a video news provider of public and private companies looking for new marketing ideas and product exposure.
Safe Harbor Statement: This release may include the use of forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Disclosure: UndiscoveredCompanies.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit our website, for complete risks and disclosures.
Contact
Immunotech Laboratories
IR@immunotechlab.com
Contact
Undiscovered Companies
info@undiscoveredcompanies.com
CSNNewswire.com
info@csnnewswire.com
SOURCE Undiscovered Companies